These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23379509)

  • 1. An emerging role for Wnt and GSK3 signaling pathways in schizophrenia.
    Singh KK
    Clin Genet; 2013 Jun; 83(6):511-7. PubMed ID: 23379509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal signaling pathways: genetic insights into the pathophysiology of major mental illness.
    Margolis RL; Ross CA
    Neuropsychopharmacology; 2010 Jan; 35(1):350-1. PubMed ID: 20010716
    [No Abstract]   [Full Text] [Related]  

  • 3. Akt/GSK3 signaling in the action of psychotropic drugs.
    Beaulieu JM; Gainetdinov RR; Caron MG
    Annu Rev Pharmacol Toxicol; 2009; 49():327-47. PubMed ID: 18928402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNT-1 and HGF regulate GSK3 beta activity and beta-catenin signaling in mammary epithelial cells.
    Papkoff J; Aikawa M
    Biochem Biophys Res Commun; 1998 Jun; 247(3):851-8. PubMed ID: 9647782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WNT unrelated activities in commercially available preparations of recombinant WNT3a.
    Cajanek L; Adlerz L; Bryja V; Arenas E
    J Cell Biochem; 2010 Dec; 111(5):1077-9. PubMed ID: 20665540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathways: epigenetic modulation of Wnt-glycogen synthase kinase-3 signaling to target human cancer stem cells.
    Benoit YD; Guezguez B; Boyd AL; Bhatia M
    Clin Cancer Res; 2014 Nov; 20(21):5372-8. PubMed ID: 25006223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action.
    Freyberg Z; Ferrando SJ; Javitch JA
    Am J Psychiatry; 2010 Apr; 167(4):388-96. PubMed ID: 19917593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destabilization of heterologous proteins mediated by the GSK3β phosphorylation domain of the β-catenin protein.
    Kong Y; Zhang H; Chen X; Zhang W; Zhao C; Wang N; Wu N; He Y; Nan G; Zhang H; Wen S; Deng F; Liao Z; Wu D; Zhang J; Qin X; Haydon RC; Luu HH; He TC; Zhou L
    Cell Physiol Biochem; 2013; 32(5):1187-99. PubMed ID: 24335169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.
    Sutton LP; Rushlow WJ
    Neuroscience; 2011 Dec; 199():116-24. PubMed ID: 22001305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia.
    Cole AR
    FEBS J; 2013 Nov; 280(21):5213-27. PubMed ID: 23796137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK3: a multifaceted kinase in Wnt signaling.
    Wu D; Pan W
    Trends Biochem Sci; 2010 Mar; 35(3):161-8. PubMed ID: 19884009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychotropic drugs and the involvement of the Akt/GSK3 signalling pathway in mental illnesses].
    Del'Guidice T; Beaulieu JM
    Med Sci (Paris); 2010; 26(6-7):647-51. PubMed ID: 20619169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia: A point of disruption.
    Ross CA; Margolis RL
    Nature; 2009 Apr; 458(7241):976-7. PubMed ID: 19396131
    [No Abstract]   [Full Text] [Related]  

  • 14. The possible role of the Akt signaling pathway in schizophrenia.
    Zheng W; Wang H; Zeng Z; Lin J; Little PJ; Srivastava LK; Quirion R
    Brain Res; 2012 Aug; 1470():145-58. PubMed ID: 22771711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT/GSK3- independent mechanism.
    Li J; Khavandgar Z; Lin SH; Murshed M
    Bone; 2011 Feb; 48(2):321-31. PubMed ID: 20932949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium for schizophrenia: supporting evidence from a 12-year, nationwide health insurance database and from Akt1-deficient mouse and cellular models.
    Luo DZ; Chang CY; Huang TR; Studer V; Wang TW; Lai WS
    Sci Rep; 2020 Jan; 10(1):647. PubMed ID: 31959776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of the calcium/protein kinase C and the canonical beta-catenin pathway by Wnt1 and Wnt7a produces opposite effects on cell proliferation in PC12 cells.
    Spinsanti P; De Vita T; Caruso A; Melchiorri D; Misasi R; Caricasole A; Nicoletti F
    J Neurochem; 2008 Mar; 104(6):1588-98. PubMed ID: 17988238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/beta-catenin pathway cross-talk and suppress medulloblastoma growth.
    Baryawno N; Sveinbjörnsson B; Eksborg S; Chen CS; Kogner P; Johnsen JI
    Cancer Res; 2010 Jan; 70(1):266-76. PubMed ID: 20028853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of soy-based changes in Wnt-frizzled signaling in prostate cancer.
    Liss MA; Schlicht M; Kahler A; Fitzgerald R; Thomassi T; Degueme A; Hessner M; Datta MW
    Cancer Genomics Proteomics; 2010; 7(5):245-52. PubMed ID: 20952759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms.
    Kim WB; Lewis CJ; McCall KD; Malgor R; Kohn AD; Moon RT; Kohn LD
    J Endocrinol; 2007 Apr; 193(1):93-106. PubMed ID: 17400807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.